Baillie Gifford & CO Johnson & Johnson Transaction History

Baillie Gifford & CO

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 24, 2023	BUY	$160.2 - $179.79 $1,441 - $1,618	9 Added 9.09%	108 $19,000
Q2 2022 Aug 08, 2022	BUY	$168.19 - $186.01 $1,681 - $1,860	10 Added 11.24%	99 $18,000
Q1 2021 May 06, 2021	BUY	$153.07 - $170.48 $153 - $170	1 Added 1.14%	89 $15,000
Q4 2020 Feb 10, 2021	BUY	$137.11 - $157.38 $12,065 - $13,849	88 New	88 $14,000
Q3 2019 Nov 07, 2019	SELL	$126.95 - $142.14 $13.4 Million - $15 Million	-105,784 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$131.15 - $144.24 $345,973 - $380,505	2,638 Added 2.56%	105,784 $14.7 Million
Q1 2019 May 01, 2019	BUY	$125.72 - $139.79 $1.04 Million - $1.16 Million	8,280 Added 8.73%	103,146 $0
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $15.6 Million - $18.8 Million	-127,011 Reduced 57.24%	94,866 $12.2 Million
Q3 2018 Nov 13, 2018	SELL	$121.58 - $142.88 $6.53 Million - $7.67 Million	-53,673 Reduced 19.48%	221,877 $30.7 Million
Q2 2018 Jul 17, 2018	BUY	$119.4 - $131.76 $1.1 Million - $1.21 Million	9,185 Added 3.45%	275,550 $33.4 Million
Q1 2018 May 10, 2018	SELL	$125.1 - $148.14 $504,903 - $597,893	-4,036 Reduced 1.49%	266,365 $34.1 Million
Q4 2017 Feb 13, 2018	SELL	$131.22 - $143.62 $10,235 - $11,202	-78 Reduced 0.03%	270,401 $37.8 Million
Q3 2017 Oct 20, 2017	BUY	$129.47 - $135.38 $1.43 Million - $1.5 Million	11,071 Added 4.27%	270,479 $35.2 Million
Q2 2017 Aug 10, 2017	BUY	N/A	259,408	259,408 $34.3 Million

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

Stay updated on Baillie Gifford & CO with notifications on news.